Marion R Munk

27PUBLICATIONS
38CO-AUTHORS
Optical technologyVision scienceNeurology and neuromuscular diseasesPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Aug 07, 2026
Aflibercept 8 mg in neovascular age-related macular degeneration and diabetic macular oedema: Translating clinical trials into clinical practice.

|Jul 11, 2026
SPECTRUM: Early clinical experience from the first global real-world study of aflibercept 8 mg in patients with diabetic macular oedema.

|Feb 28, 2026
Correction: One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report.

Anne Tillmann, Richard Stillenmunkes, Justus G Garweg

|Jan 30, 2026
SPECTRUM: early clinical experience from the first global real-world study of aflibercept 8 mg in patients with neovascular age-related macular degeneration.

Clare Bailey, Clemens Lange, Varun Chaudhary

|Jan 16, 2026
Infographic: SPECTRUM: study design of the global real-world study of aflibercept 8 mg in the treatment of neovascular age-related macular degeneration and diabetic macular edema.

Clare Bailey, Clemens Lange, Marion R Munk

|Jan 06, 2026
Distinguishing Inherited Retinal Disease From Age-Related Macular Degeneration: Clinical Red Flags, Diagnostic Strategy, and the Expanding Role of Genetic Testing.

Ditta Zobor, Marion R Munk

Pageof 5

Frequent Collaborators

4 joint publications

Varun Chaudhary

3 joint publications

Meng Tian

3 joint publications

Tobias Machewitz

3 joint publications

Marc D de Smet